BNGO
Bionano Genomics, Inc.
NASDAQ · Healthcare · Medical - Diagnostics & Research · US
$1.73
−0.57%2
Insider buys (3m)
0
Insider sells (3m)
$9.7K
Net value (3m)
+50.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Sep 9, 2026 | Luderer Albert · director, officer: Interim Chief Executive | Purchase | 4,000 | $1.21 |
| Aug 21, 2026 | Luderer Albert · director, officer: Interim Chief Executive | Purchase | 4,000 | $1.22 |
| Aug 5, 2026 | OLDAKOWSKI MARK · officer: Chief Operating Officer | A-Award | 15,000 | $1.12 |
| Aug 5, 2026 | Adamchak Mark · officer: Principal Accounting Officer | A-Award | 5,000 | $1.12 |
| Aug 5, 2026 | Hastie Alex Reid · officer: Chief Scientific Officer | A-Award | 54,000 | $1.12 |
| Aug 5, 2026 | Dixon Jonathan V. · officer: General Counsel | A-Award | 15,000 | $1.12 |
| Jun 3, 2026 | OLDAKOWSKI MARK · officer: CHIEF OPERATING OFFICER | F-InKind | 27 | $1.30 |
| Jun 3, 2026 | Adamchak Mark · officer: Principal Accounting Officer | F-InKind | 7 | $1.30 |
| Jun 3, 2026 | Dixon Jonathan V. · officer: GENERAL COUNSEL | F-InKind | 24 | $1.30 |
| Jun 3, 2026 | Chaubey Alka · officer: CHIEF MEDICAL OFFICER | F-InKind | 24 | $1.30 |
| May 14, 2026 | Rajkovic Aleksandar · director | A-Award | 9,149 | $1.19 |
| May 14, 2026 | TWOMEY CHRISTOPHER J · director | A-Award | 9,149 | $1.19 |
| May 14, 2026 | Vuori Kristiina MD · director | A-Award | 9,149 | $1.19 |
| May 14, 2026 | Linney Yvonne · director | A-Award | 9,149 | $1.19 |
| May 14, 2026 | BARKER DAVID L · director | A-Award | 9,149 | $1.19 |
| Feb 18, 2026 | Dixon Jonathan V. · officer: GENERAL COUNSEL | F-InKind | 6 | $1.10 |
| Feb 18, 2026 | OLDAKOWSKI MARK · officer: CHIEF OPERATING OFFICER | F-InKind | 20 | $1.10 |
| Feb 18, 2026 | Adamchak Mark · officer: Principal Accounting Officer | F-InKind | 3 | $1.10 |
| Feb 18, 2026 | Chaubey Alka · officer: CHIEF MEDICAL OFFICER | F-InKind | 18 | $1.10 |
| Feb 18, 2026 | Holmlin R. Erik · director, officer: PRESIDENT AND CEO | F-InKind | 51 | $1.10 |
| Feb 4, 2026 | Dixon Jonathan V. · officer: GENERAL COUNSEL | A-Award | 26,117 | $1.27 |
| Feb 4, 2026 | Chaubey Alka · officer: CHIEF MEDICAL OFFICER | A-Award | 27,737 | $1.27 |
| Feb 4, 2026 | OLDAKOWSKI MARK · officer: CHIEF OPERATING OFFICER | A-Award | 27,737 | $1.27 |
| Feb 4, 2026 | Holmlin R. Erik · director, officer: PRESIDENT AND CEO | A-Award | 69,484 | $1.27 |
| Feb 4, 2026 | Adamchak Mark · officer: Principal Accounting Officer | A-Award | 10,890 | $1.27 |
| Sep 12, 2025 | OLDAKOWSKI MARK · officer: Chief Operating Officer | F-InKind | 59 | $4.06 |
| Sep 12, 2025 | Chaubey Alka · officer: Chief Medical Officer | F-InKind | 51 | $4.06 |
| Jun 12, 2025 | Vuori Kristiina MD · director | A-Award | 2,775 | $3.67 |
| Jun 12, 2025 | TWOMEY CHRISTOPHER J · director | A-Award | 2,775 | $3.67 |
| Jun 12, 2025 | Linney Yvonne · director | A-Award | 2,775 | $3.67 |
Institutional positioning
13F filings over the trailing two quarters
New 17Increased 20Reduced 6Sold out 7
| Filer | Action | Shares | Filed |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | Increased | 353,363 | May 8, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 167,533 | May 15, 2026 |
| GSA CAPITAL PARTNERS LLP | Reduced | 150,284 | Aug 6, 2026 |
| CARRET ASSET MANAGEMENT, LLC | Increased | 125,000 | Aug 4, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 89,993 | Aug 12, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Increased | 82,388 | Aug 13, 2026 |
| CARRET ASSET MANAGEMENT, LLC | Increased | 70,000 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 68,109 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 51,578 | May 8, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Unchanged | 51,578 | Aug 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 51,100 | Aug 13, 2026 |
| RENAISSANCE TECHNOLOGIES LLC | Increased | 48,700 | May 14, 2026 |
| JANE STREET GROUP, LLC | New Position | 35,728 | Aug 14, 2026 |
| PRUDENTIAL FINANCIAL INC | Increased | 31,600 | Aug 12, 2026 |
| PRUDENTIAL FINANCIAL INC | New Position | 28,000 | May 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 9, 2026